928 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
AGN Allergan plc. $160.59 $53.41B Sell
Article Searches
Arnold Van Den Berg Buys Allergan PLC, Ensco PLC, Apache Corp, Sells Atwood Oceanics Inc, ... http://www.gurufocus.com/news/634384/arnold-van-den-berg-buys-allergan-plc-ensco-plc-apache-corp-sells-atwood-oceanics-inc-cerner-corp-dollar-tree-inc Feb 02, 2018 - Arnold Van Den Berg Buys Allergan PLC, Ensco PLC, Apache Corp, Sells Atwood Oceanics Inc, Cerner Corp, Dollar Tree Inc, Stocks: ESV,APA,FFXDF,01099,SLB,AGN,MUR,VZ,DO,DWSN,ATW,CER, release date:Feb 02, 2018
Kicking Off Avisol's 'Theme Of The Month' Series With A Look At NASH And Intercept https://seekingalpha.com/article/4142629-kicking-avisols-theme-month-series-look-nash-intercept?source=feed_sector_healthcare Feb 02, 2018 - We're starting off this series with NASH, which is getting increasing interest from investors.There’s a crowded clinical development pipeline, so the trick is to choose the best few stocks.A brief loo
Your Daily Pharma Scoop: Synergy Update, Vertex Results, Affimed Data https://seekingalpha.com/article/4142339-daily-pharma-scoop-synergy-update-vertex-results-affimed-data?source=feed_sector_healthcare Feb 02, 2018 - Synergy met cash balance requirement to access additional capital under its term loan agreement.Vertex reported results and advanced VX-659 and VX-445 to phase 3.Affimed announced promising data for l
Teva Completes Sale of Women's Health Segment for $703M http://www.zacks.com/stock/news/291212/teva-completes-sale-of-womens-health-segment-for-%24703m?cid=CS-ZC-FT-291212 Feb 02, 2018 - Teva Pharmaceutical (TEVA) sells woman health specialty products for cash consideration of $703 million.
Allergan's Anti-Infective Drug Avycaz Receives Third FDA Nod http://www.zacks.com/stock/news/291192/allergans-anti-infective-drug-avycaz-receives-third-fda-nod?cid=CS-ZC-FT-291192 Feb 02, 2018 - The FDA's label expansion approval for Allergan's (AGN) Avycaz marks its third therapeutic indication nod for the anti-infective drug in the United States.
Engineers Gate Manager LP Buys MGIC Investment Corp, PBF Energy Inc, PepsiCo Inc, Sells SPDR ... http://www.gurufocus.com/news/633852/engineers-gate-manager-lp-buys-mgic-investment-corp-pbf-energy-inc-pepsico-inc-sells-spdr-sp-500-workday-inc-expedia-inc Feb 01, 2018 - Engineers Gate Manager LP Buys MGIC Investment Corp, PBF Energy Inc, PepsiCo Inc, Sells SPDR S&P 500, Workday Inc, Expedia Inc, Stocks: PCG,AON,NVDA,AGN,RL,MRVL,MTG,UPS,XEL,PBF,SNPS,PEP,, release date:Feb 01, 2018
Vanguard Health Care Fund Buys Danaher, CVS Health, Adds to Allergan http://www.gurufocus.com/news/633587/vanguard-health-care-fund-buys-danaher-cvs-health-adds-to-allergan Feb 01, 2018 - Vanguard Health Care Fund Buys Danaher, CVS Health, Adds to Allergan, Stocks: DHR,AGN,CVS,IQV,TSRO,4523.JAPAN,TEVA,NKTR,ARE, Vanguard Health Care Fund, release date:Feb 01, 2018
Bnp Paribas Arbitrage, Sa Buys Alibaba Group Holding, Allergan PLC, iShares Core S&P 500, ... http://www.gurufocus.com/news/633705/bnp-paribas-arbitrage-sa-buys-alibaba-group-holding-allergan-plc-ishares-core-sp-500-sells-apple-inc-spdr-sp-500-powershares-qqq-trust-series-1 Feb 01, 2018 - Bnp Paribas Arbitrage, Sa Buys Alibaba Group Holding, Allergan PLC, iShares Core S&P 500, Sells Apple Inc, SPDR S&P 500, PowerShares QQQ Trust Series 1, Stocks: BABA,AGN,IVV,PCG,DE,IBB,GDXJ,CNI,ES,TPR,NCLH,EPHE,, release date:Feb 01, 2018
RiverPark Focused Value Fund Q4 2017 Performance Summary https://seekingalpha.com/article/4142155-riverpark-focused-value-fund-q4-2017-performance-summary?source=feed_all_articles Feb 01, 2018 - Includes detailed analysis of RiverPark Focused Value Fund's positions in LEA, VST.In Q4 2017, the Fund returned 4.90% as compared with the total return of the Russell 1000 Value Index of 5.33%. The t
Allergan (AGN) to Report Q4 Earnings: What's in the Cards? http://www.zacks.com/stock/news/291003/allergan-agn-to-report-q4-earnings-whats-in-the-cards?cid=CS-ZC-FT-291003 Feb 01, 2018 - While Allergan's (AGN) Q4 sales are likely to be driven by new as well as established products like Botox and international growth, generic competition for some key products will hurt sales.

Pages: 1234567891011...93

<<<Page 6>